TrialThe journal of prevention of Alzheimer's disease2025

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

Stephen Macfarlane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.